Approval · Notice of Compliance 38352 · 2026
VISKAZIDE: Notice of Compliance 38352
Issued September 25, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38352
- Date
- September 25, 2026
- Company
- Xediton Pharmaceuticals Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph as per advisement letter. Product Monograph reformatted to the Master Template
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VISKAZIDE | Not yet assigned | — |
Medicinal ingredients
- HYDROCHLOROTHIAZIDE 50 MG per TAB
- PINDOLOL 10 MG per TAB
- HYDROCHLOROTHIAZIDE 25 MG per TAB